Kentucky BioProcessing has joined the coronavirus vaccine race and is using tobacco to do it. The vaccine is currently in pre-clinical testing, but Kentucky BioProcessing did clone a portion of COVID-19's genetic sequence which led to the development of a potential antigen. Kentucky BioProcessing intended to carry out the vaccine operation in a nonprofit manner.